Literature DB >> 10567178

Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass.

V Palmieri1, G de Simone, M J Roman, J E Schwartz, T G Pickering, R B Devereux.   

Abstract

Appropriateness of left ventricular (LV) mass to cardiac workload can be evaluated by the ratio of observed LV mass to the value predicted for an individual's gender, height(2.7), and stroke work at rest (%PLVM). It is unclear which pathophysiological factors are associated with inappropriately high LV mass in hypertensive subjects. Adequate LV mass was defined by the 90% confidence interval (73% to 128%) of the distribution of %PLVM in 393 normal-weight normotensive subjects. In 185 hypertensive subjects (aged 56+/-11 years; 60% male, 29% black), according to %PLVM, 164 (88%) had adequate LV mass, 16 (9%) had inappropriately high LV mass (%PLVM >128%), and 5 (3%) had %PLVM <73% (low LV mass). Age, gender, smoking habit, proportion of never-treated subjects, total cholesterol, triglycerides, and creatinine levels did not differ significantly between subjects with adequate and inappropriately high LV mass. Body mass index, fasting glucose, and proportion of black subjects were higher (all P<0.05), while HDL cholesterol was lower (P<0.05) in subjects with inappropriately high LV mass. Blood pressure at the echocardiogram was comparable between subjects with adequate and inappropriately high LV mass, but the latter group had higher ambulatory blood pressure (P<0.01). Subjects with inappropriately high LV mass also had higher aortic root dimension and LV relative wall thickness and relatively lower LV systolic performance than those with adequate LV mass (all P<0.001). Larger aortic root diameter and lower systolic function were also found in hypertensive subjects with inappropriate LV hypertrophy compared with those with adequate LV hypertrophy. In an exploratory case-control study that compared subjects with low %PLVM with age-matched counterparts with adequate LV mass, low %PLVM was associated with lower body mass index, more favorable metabolic profile, and higher LV myocardial contractility. Higher body mass index, larger aortic root, and black race were independent correlates of increased %PLVM. Thus, in arterial hypertension, levels of LV mass inappropriately high for gender, cardiac workload, and height(2.7) are associated with higher body mass index, higher ambulatory blood pressure, larger aortic root diameters, and relatively low myocardial contractility.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567178     DOI: 10.1161/01.hyp.34.5.1032

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

1.  Echocardiographic Predictors of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study.

Authors:  Suma H Konety; Ryan J Koene; Faye L Norby; Tony Wilsdon; Alvaro Alonso; David Siscovick; Nona Sotoodehnia; John Gottdiener; Ervin R Fox; Lin Y Chen; Selcuk Adabag; Aaron R Folsom
Journal:  Circ Cardiovasc Imaging       Date:  2016-08       Impact factor: 7.792

2.  Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors.

Authors:  Maya Peer; Mona Boaz; Matas Zipora; Marina Shargorodsky
Journal:  Int J Angiol       Date:  2013-12

3.  Inadequate RAAS suppression is associated with excessive left ventricular mass and systo-diastolic dysfunction.

Authors:  Mario Gregori; Giuliano Tocci; Andrea Marra; Giulia Pignatelli; Caterina Santolamazza; Alberto Befani; Giuseppino Massimo Ciavarella; Andrea Ferrucci; Francesco Paneni
Journal:  Clin Res Cardiol       Date:  2013-06-14       Impact factor: 5.460

4.  Non-Dipper Pattern is a Determinant of the Inappropriateness of Left Ventricular Mass in Essential Hypertensive Patients.

Authors:  Bae Keun Kim; Young-Hyo Lim; Hyung Tak Lee; Jae Ung Lee; Kyung Soo Kim; Soon Gil Kim; Jeong Hyun Kim; Heon Kil Lim; Jinho Shin
Journal:  Korean Circ J       Date:  2011-04-30       Impact factor: 3.243

5.  Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects.

Authors:  Liliana Legedz; Giampiero Bricca; Pierre Lantelme; Marie-Odile Rial; Pierre Champomier; Madeleine Vincent; Hugues Milon
Journal:  Vasc Health Risk Manag       Date:  2006

6.  Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study.

Authors:  Maria Francesca Evaristi; Céline Caubère; Romain Harmancey; Franck Desmoulin; William Frank Peacock; Matthieu Berry; Annie Turkieh; Manon Barutaut; Michel Galinier; Camille Dambrin; Carlo Polidori; Cristina Miceli; Bernard Chamontin; François Koukoui; Jerôme Roncalli; Pierre Massabuau; Fatima Smih; Philippe Rouet
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart Study.

Authors:  D Edmund Anstey; Rikki M Tanner; John N Booth; Adam P Bress; Keith M Diaz; Mario Sims; Gbenga Ogedegbe; Paul Muntner; Marwah Abdalla
Journal:  J Am Heart Assoc       Date:  2019-08-13       Impact factor: 5.501

8.  Hyperuricemia Is Associated with Left Ventricular Dysfunction and Inappropriate Left Ventricular Mass in Chronic Kidney Disease.

Authors:  Tai-Hua Chiu; Pei-Yu Wu; Jiun-Chi Huang; Ho-Ming Su; Szu-Chia Chen; Jer-Ming Chang; Hung-Chun Chen
Journal:  Diagnostics (Basel)       Date:  2020-07-24

9.  Association between inappropriateness of left ventricular mass and left ventricular diastolic dysfunction: a study using the tissue Doppler parameter, e/e'.

Authors:  Young Hyo Lim; Jae Ung Lee; Kyung Soo Kim; Soon Gil Kim; Jeong Hyun Kim; Heon Kil Lim; Bang Hun Lee; Jinho Shin
Journal:  Korean Circ J       Date:  2009-04-28       Impact factor: 3.243

10.  Type 2 diabetes mellitus-related changes in left ventricular structure and function in patients with chronic kidney disease.

Authors:  Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen; Ling-I Chen
Journal:  Oncotarget       Date:  2018-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.